Ms. Lana Culley reports

AURORA GRANTED PLANT BREEDERS' RIGHTS, STRENGTHENING LEADERSHIP IN CANNABIS SCIENCE

Aurora Cannabis Inc. has been granted Plant Breeders' Rights in Canada for two proprietary cannabis cultivars developed through its world-class breeding program. This certification gives Aurora the exclusive rights to grow, propagate and sell finished products produced from these varieties.

The two protected cultivars, SOT20R07-007 (known as Farm Gas) and SOT20R07-005 (known as Driftwood Diesel), were developed at Aurora Coast, Aurora's industry-leading research and development facility in Comox, B.C. The company carefully selected these cultivars based on their unique characteristics, including how well they grow and how consistently they perform. Farm Gas and Driftwood Diesel are core medical cannabis products available to patients in Germany, Poland, United Kingdom, Canada and Australia.

"These Plant Breeders' Rights recognize the depth of work behind our leading breeding, genetic development and testing program," says Lana Culley, vice-president, innovation and international operations, at Aurora. "They reflect a disciplined, science-driven approach to developing cultivars that deliver consistency, performance and reliability for medical cannabis patients around the world."

Understanding Plant Breeders' Rights in Canada

• Plant Breeders' Rights are a form of intellectual property protection, similar to patents, that apply specifically to new and distinct plant varieties.
• In Canada, Plant Breeders' Rights are granted by the Canadian Food Inspection Agency (CFIA) and give breeders exclusive rights to produce and sell a protected plant variety.
• This framework recognizes the significant scientific investment required to develop cultivars that are clearly different and produce the same results over time.
• For Aurora, plant breeders' rights protect proprietary cannabis genetics developed through its internal breeding program, supporting continued innovation and long-term research.

Aurora's robust genetics platform underpins its global medical cannabis leadership and supports the company's ability to develop differentiated premium products with consistent and reliable attributes. The protection of these varieties, as well as the recent grants received for select variety protection in Europe, enhances Aurora's competitive position globally.

About Aurora Cannabis Inc.

Aurora is a global leader in medical cannabis, dedicated to improving lives through scientific expertise, proven performance and a deep commitment to patient care. Aurora serves both medical and consumer markets across Canada, Europe, Australia and New Zealand, with a strategic focus on high-margin opportunities and a medical-first approach. Aurora's portfolio of trusted, leading brands includes Aurora, MedReleaf, Pedanios, IndiMed, San Raf, Tasty's and Whistler Medical Marijuana Co.. With world-class good-manufacturing-practice-certified manufacturing facilities in Canada and Germany, and a team of industry-leading professionals, Aurora continues to expand its global footprint and deliver consistent, high-quality cannabis products with the purpose of opening the world to Cannabis.

We seek Safe Harbor.